JP2024540532A5 - - Google Patents

Info

Publication number
JP2024540532A5
JP2024540532A5 JP2024529550A JP2024529550A JP2024540532A5 JP 2024540532 A5 JP2024540532 A5 JP 2024540532A5 JP 2024529550 A JP2024529550 A JP 2024529550A JP 2024529550 A JP2024529550 A JP 2024529550A JP 2024540532 A5 JP2024540532 A5 JP 2024540532A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540532A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/080182 external-priority patent/WO2023092098A1/en
Publication of JP2024540532A publication Critical patent/JP2024540532A/ja
Publication of JP2024540532A5 publication Critical patent/JP2024540532A5/ja
Pending legal-status Critical Current

Links

JP2024529550A 2021-11-18 2022-11-18 複素環式アミド及びその使用方法 Pending JP2024540532A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163280939P 2021-11-18 2021-11-18
US63/280,939 2021-11-18
PCT/US2022/080182 WO2023092098A1 (en) 2021-11-18 2022-11-18 Heterocyclic amides and methods of using the same

Publications (2)

Publication Number Publication Date
JP2024540532A JP2024540532A (ja) 2024-10-31
JP2024540532A5 true JP2024540532A5 (enExample) 2025-11-27

Family

ID=84923227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529550A Pending JP2024540532A (ja) 2021-11-18 2022-11-18 複素環式アミド及びその使用方法

Country Status (11)

Country Link
US (1) US20250066389A1 (enExample)
EP (1) EP4433457A1 (enExample)
JP (1) JP2024540532A (enExample)
KR (1) KR20240133696A (enExample)
CN (1) CN118786117A (enExample)
AU (1) AU2022390051A1 (enExample)
CA (1) CA3238521A1 (enExample)
IL (1) IL312843A (enExample)
MX (1) MX2024006065A (enExample)
TW (1) TW202334093A (enExample)
WO (1) WO2023092098A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025211457A1 (ja) * 2024-04-05 2025-10-09 日本新薬株式会社 Cugリピートrnaとmbnlタンパクとの結合阻害化合物および医薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019028440A1 (en) * 2017-08-04 2019-02-07 Skyhawk Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MODULATING SPLICING
US11129829B2 (en) * 2019-06-17 2021-09-28 Skyhawk Therapeutics, Inc. Methods for modulating splicing

Similar Documents

Publication Publication Date Title
JP2024540532A5 (enExample)
JP2020525426A5 (enExample)
AR080870A1 (es) Propanoato cristalino de (s)-isopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino, composiciones farmaceuticas que los contienen y uso del mismo en el tratamiento de infecciones virales, en particul
HRP20241197T1 (hr) Makrociklični spojevi i primjene istih
CN107001858B (zh) 包含改性的二有机硅氧烷聚合物的化合物
JP2008505858A5 (enExample)
FI3558390T3 (fi) Amanitinivasta-ainekonjugaatit
JP2019532928A5 (enExample)
JP2016529230A5 (enExample)
JP2003508539A5 (enExample)
HUP9901150A2 (hu) Baktériumok kolonizációjának gátlására szolgáló oligoszacharidokat tartalmazó gyógyszerkészítmény
RU2011113402A (ru) ПИРИДО[5,4d]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ПРОЛИФЕРАЦИИ КЛЕТОК
AR043831A1 (es) Derivados de pirrodilina y procedimiento para prepararlos
RU2007136535A (ru) Пептидомиметические соединения и получение биологически активных производных
JP2005536465A5 (enExample)
AR046632A1 (es) Derivados de pirazolilo, procedimiento de preparacion y productos intermedios de este procedimiento a modo de medicamentos y composiciones farmaceuticas que los contienen
RU2009101150A (ru) Противоопухолевые соединения дигидропиран-2-она
JPWO2020004649A5 (enExample)
JP2014528905A5 (enExample)
JP2024009799A5 (enExample)
ES2466025T3 (es) La síntesis de ecteinascidinas de origen natural y compuestos relacionados
JP2024506667A5 (enExample)
JP2020525502A5 (enExample)
WO2016133365A1 (ko) 알루미늄 화합물 및 이를 이용한 알루미늄-함유 막의 형성 방법
CA2463544A1 (en) Cross-linked glycopeptide-cephalosporin antibiotics